Harpoon Therapeutics Corp - HARP Net Assets per Single Share

The current book value per share reflects the financial standing of Harpoon Therapeutics (HARP), where the value 1.12 determines the parameter status. Capital dynamics are driven by an acquisition by a tech giant for the global implementation of T-cell activators. Drug development is based on strict ethical standards and environmental safety. The expert team is sustained by the ability to create innovations with the support of the largest pharmaceutical behemoths.

HARP: Harpoon Tx Net Asset Value per Share 07/04/2022 - 03/16/2024

harpoontx.com - analytical breakdowns and key metrics (HARP)

- price and consensus price forecast:

Price Chart Harpoon Tx|HARP - Fair Value Consensus

- market capitalization data:

Market Value Harpoon Therapeutics, Inc.|HARP - Full Business Value

- book capitalization data:

Net Assets per Single Share Harpoon Therapeutics|HARP - Total Stockholders' Equity|Market Value to Book Value Ratio harpoontx.com|HARP - Total Business Assets

- debt and liquidity data:

Total Debt to Capital Harpoon Therapeutics|HARP - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Harpoon Therapeutics, Inc.|HARP - Company Cumulative Debt|Debt to Book Capitalization Ratio Harpoon Therapeutics, Inc.

Fundamental company valuation:HARP - Harpoon Tx

Flagship merchandise of Harpoon Therapeutics, Inc.

To objectively evaluate the issuer, a manager requires a net asset value per share calculation, which determines the residual value of the business after all liabilities are settled. By analyzing the book value per share, an investor sees the real capital of Harpoon Therapeutics (HARP), backed by the protected TriTAC patent platform and the integration of R&D assets into oncology holdings, which creates a fundamental foundation of stability.

Competitor analysis for Harpoon Therapeutics